Why India's hepatitis crisis needs urgent attention
Understanding hepatitis
Hepatitis refers to inflammation of the liver, primarily caused by five viruses: A, B, C, D, and E. Hepatitis A and E are transmitted through contaminated food or water and usually result in acute illness. Hepatitis B, C, and D, however, are more insidious and are transmitted through blood, unsafe medical procedures, unprotected sex, or from mother to child. If left untreated, these can lead to chronic liver disease, cirrhosis, or liver cancer.
According to the World Health Organization's 2024 Global Hepatitis Report, India bears the world's second-highest burden, with 2.98 crore Hepatitis B and 55 lakh Hepatitis C cases. Alarmingly, nearly 90% of those infected are unaware of their condition and often present only when irreversible liver damage has set in. Despite the availability of vaccines for Hepatitis A and B, and curative treatments for Hepatitis C, hepatitis still claims one life every 30 seconds.
Challenges that need addressing
In line with the WHO's target to eliminate viral hepatitis as a public health threat by 2030, India must address pressing challenges such as high diagnostic costs, limited screening, and persistent stigma. Strengthening the healthcare response through routine screening, community-level education, and policies that ensure affordable access to diagnostics and treatment is essential.
Across the country, public health institutions, medical colleges, and civil society partners are intensifying efforts through awareness campaigns, screening programs, and policy advocacy to improve access to diagnosis and treatment. Recent initiatives have included national summits bringing together experts and stakeholders to develop comprehensive elimination strategies.
On this World Hepatitis Day, let's break the silence, end the stigma, and build a hepatitis-free world.
Join the movement. Get tested, get treated, and protect your family.
(Dr. Vivek Shanmugam is a liver transplant surgeon & managing trustee, Chennai Liver Foundation . Info@chennailiverfoundation.org)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
28 ventilators lie idle in Hazaribag hosp since 2020, superintendent assures action
1 2 Hazaribag: Since the height of the Covid-19 in 2020, 28 life-saving ventilators have been gathering dust in the ICU of Sheikh Bhikhari Medical College Hospital, unused and forgotten, Hazaribag's Sadar MLA, Pradip Prasad, has raised alarm over this critical healthcare oversight at the health unit. These machines, purchased to combat the pandemic, have yet to see the light of day, leaving patients in dire need to be referred to Ranchi for critical care. Prasad has called this not just negligence but a dangerous gamble with the lives of those seeking medical help. He has demanded swift action from the state health department to rectify this oversight immediately. Speaking to TOI, Prasad said, "These ventilators have been sitting idle for years. No steps were taken to operationalise them, nor was there any effort to appoint trained operators. This is a grave disservice to our community." Prasad also highlighted shone a light on other pressing issues plaguing the hospital, including cleanliness, a shortage of medicines, poorly maintained equipment, and a lack of staff. He stressed the urgent need for solutions. In response to Prasad's concerns, his team met with the hospital superintendent, Dr Anukaran Purti, to delve into these issues. They discussed the hospital's current system, resource status, and the challenges faced on the ground. Purti, acknowledging the gravity of the situation, promised swift action. "I will address these issues, including the ventilators, to ensure they are operational soon," he said.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
WHO updates recommendations on use of antibiotics for Covid-19 patients
The WHO has recommended against the use of antibiotics even in patients with severe Covid when a concurrent bacterial infection is not suspected. The global health body has released updated recommendations for the clinical management of people with Covid which, it said, are based on evidence generated from recent meta-analysis of outcomes of patients treated with antibiotics for Covid. "For patients with non-severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we recommend no empirical antibiotics. For patients with severe COVID-19 and a low clinical suspicion of a concurrent bacterial infection, we suggest no empirical antibiotics," the WHO said. The WHO said that as COVID-19 epidemiology and severity have changed, and as emergency measures have subsided, the evidence behind a number of recommendations has changed. In parallel, evolution of health systems and the global environment have meant that the recommendations are implemented in a very different context in 2024 compared to 2020. These guidelines have evolved from the first version in 2020 in line with new information and changing circumstances of the pandemic, the WHO said. "Notable changes to COVID-19 disease over this time have been overall reduced infection rates and reduced disease severity. Emergency measures which were imposed have also been removed, and care for patients with COVID-19 has become more integrated with usual healthcare systems. "This different environment has prompted a review of the scope and content of all existing guidance. In order to maintain a clear focus and relevance, we have removed recommendations which would be considered general medical principles, and those which are no longer specific to the management of COVID-19," the WHO said. The new recommendations on use of antibiotics were prompted by the publication of data from a systematic review and meta-analysis, and the pressing need to address antimicrobial resistance. The WHO said that the updated guidelines are for people directly or indirectly involved in the health care of patients with COVID-19 and post COVID-19 condition. This includes clinicians, allied health care workers, facility managers and hospital administrators. The SARS-CoV-2 continues to infect several thousands of people daily leading to preventable morbidity and mortality across the world, the WHO said. The roll-out of vaccines and treatment for COVID-19, and increasing population immunity from infection has substantially reduced hospitalization, severity of disease, and mortality. "However, the virus continues to evolve in terms of infectivity, immune escape, and disease severity. This guideline robustly and transparently addresses the changing landscape and evidence availability, and the continual development of treatment and management strategies for COVID-19," the WHO stated. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Economic Times
2 hours ago
- Economic Times
RFK Jr. shocks big pharma, yanks $500 million from mRNA vaccine projects, including for Flu and COVID
RFK Jr. explains why he is stopping mRNA vaccines Live Events Big drug companies will lose money and research Pulled back on promoting COVID-19 shots Fired the panel that gives vaccine advice to the government Stayed silent on promoting vaccines during a measles outbreak that's getting worse FAQs (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel RFK Jr. cancels vaccine projects worth $500 million. On Tuesday, August 5, 2025, U.S. Health Secretary Robert F. Kennedy Jr. announced he is shutting down 22 vaccine projects. These projects were using mRNA technology, and were funded by the Department of Health and Human Services (HHS).Projects were targeting major viruses. The cancelled vaccines were being developed to fight COVID-19, influenza (flu), and H5N1 bird flu. These viruses can cause serious illness, and the projects were meant to help prevent future outbreaks, according to the report by Associated Jr. made the announcement in Alaska. Kennedy shared the news during a press conference in Anchorage, Alaska, standing beside Republican Senators Dan Sullivan and Lisa Murkowski. He posted a video explaining his decision. On his social media, Kennedy released a video where he criticized mRNA vaccines, saying they are 'troubled' and fail when viruses wants to replace mRNA with other vaccine types. Instead of mRNA, Kennedy said the U.S. will focus on creating vaccines using whole-virus methods and new platforms that he believes are safer and more durable, as stated in the report by Associated Press. Pfizer and Moderna are directly affected. Some of the biggest drug companies in the U.S., including Pfizer and Moderna, were working on the now-cancelled mRNA vaccine projects. These companies are major players in vaccine is part of Kennedy's bigger anti-vaccine agenda. Since becoming health secretary, Kennedy has taken several controversial steps:The move has shocked health experts and Big Pharma. The sudden cancellation of such a large amount of vaccine funding has stunned the medical world and Big Pharma, who depend on government support for vaccine research and development, as mentioned in the report by Associated Jr. said he canceled the mRNA vaccine projects because he believes they don't work well when viruses change and are not safe and Moderna are directly affected, as they were working on the canceled government-funded mRNA vaccine projects.
